CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company that commercializes small-molecule therapeutics to treat serious or life-threatening medical conditions by increasing the amount of oxygen to hypoxic tissues. Its products include trans sodium crocetin and trans bipolar carotenoid molecules, for treating life-threatening conditions, such as trauma, cancer, stroke, cardiovascular diseases, respiratory disorders, peripheral vascular and arterial diseases, and various other conditions.